Organon Q4 2023 Earnings Presentation - Full Year Results

Organon's fourth quarter and full year 2023 earnings presentation includes financial performance results, 2024 guidance estimates, and updates on product franchises and commercialization strategy. The presentation covers non-GAAP financial measures including Adjusted EBITDA, Adjusted gross margin, and Adjusted diluted EPS, with reconciliations to GAAP results. Forward-looking statements address the company's product development plans, business development strategy, and market position in contraception and fertility products.